Literature DB >> 8080410

Generalised granuloma annulare successfully treated with pentoxifylline.

D M Rubel1, G Wood, R Rosen, A Jopp-McKay.   

Abstract

Generalised granuloma annulare (GA) is a chronic disease of unknown aetiology and is recalcitrant to many treatment regimes. Some investigators have suggested that an immune medicated vasculitis may be involved in the pathogenesis of GA. We describe a patient with a ten year history of generalised GA, who showed dramatic clearing of the majority of papules after four weeks of treatment with pentoxifylline. This drug has shown promising results in the treatment of many dermatologic disorders including necrobiosis lipoidica diabeticorum, leukocytoclastic vasculitis and Raynaud's phenomenon. Pentoxifylline is thought to reduce blood viscosity via effects on all major blood components, and its clinical effectiveness in generalised GA lends support to a model of immune-medicated vasculitis in the pathogenesis of this disorder. Thus, pentoxifylline offers a well-tolerated and effective alternative to the treatment options available for patients with granuloma annulare.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8080410     DOI: 10.1111/j.1440-0960.1993.tb00875.x

Source DB:  PubMed          Journal:  Australas J Dermatol        ISSN: 0004-8380            Impact factor:   2.875


  3 in total

Review 1.  Unconventional uses of common conventional drugs: A review.

Authors:  Anupam Das; Abheek Sil; Shouvik Ghosh; Saumya Panda
Journal:  Indian J Dermatol Venereol Leprol       Date:  2021 Jul-Aug       Impact factor: 2.545

2.  Pentoxifylline and its applications in dermatology.

Authors:  Iffat Hassan; Konchok Dorjay; Parvaiz Anwar
Journal:  Indian Dermatol Online J       Date:  2014-10

3.  Successful Treatment of Generalized Granuloma Annulare with Pentoxifylline.

Authors:  Keerthi G Nambiar; Soumya Jagadeesan; Pradeep Balasubramanian; Jacob Thomas
Journal:  Indian Dermatol Online J       Date:  2017 May-Jun
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.